Ultralife
ULBI
51 hedge funds and large institutions have $42.4M invested in Ultralife in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 18 closing their positions.
300% more call options, than puts
Call options by funds: $28K | Put options by funds: $7K
3.42% less ownership
Funds ownership: 34.83% → 31.42% (-3.4%)
7% less funds holding
Funds holding: 55 → 51 (-4)
8% less capital invested
Capital invested by funds: $46M → $42.4M (-$3.61M)
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$1.58M |
| 2 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$1.27M |
| 3 |
Millennium Management
New York
|
+$670K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$376K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$338K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.44M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$990K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$958K |
| 4 |
State Street
Boston,
Massachusetts
|
-$885K |
| 5 |
Renaissance Technologies
New York
|
-$825K |
ULBI Hedge Fund Activity: Q2 2021 in Review
51 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ultralife (ULBI) for Q2 2021, worth a combined $42.4M — down 7.8% from $46M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ULBI and 14 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 14 added.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $1.58M. The largest seller was BlackRock, cutting an estimated $3.44M.
- 51 institutional investors held Ultralife (ULBI) as of Q2 2021, down from 55 in Q1 2021.
- Funds reported $42.4M of Ultralife stock for Q2 2021, down 7.8% quarter-over-quarter.
- 14 funds opened new Ultralife positions in Q2 2021 and 18 closed out, a net change of -4 holders.
- The largest Ultralife buyer in Q2 2021 was Russell Investments Group, an estimated $1.58M added.
- The largest Ultralife seller in Q2 2021 was BlackRock, an estimated $3.44M sold.
Based on aggregated 13F filings for Q2 2021.